NOVELION THERAPEUTICS INC's ticker is NVLNF and the CUSIP is 67001K202. A total of 37 filers reported holding NOVELION THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 1.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $421,000 | -41.2% | 581,042 | -36.7% | 0.06% | +29.8% |
| Q2 2019 | $716,000 | -38.5% | 918,342 | -3.0% | 0.05% | +30.6% |
| Q1 2019 | $1,165,000 | +46.5% | 946,842 | 0.0% | 0.04% | +56.5% |
| Q4 2018 | $795,000 | -86.8% | 946,842 | +10.3% | 0.02% | -74.4% |
| Q3 2017 | $6,033,000 | -43.5% | 858,144 | -25.8% | 0.09% | -43.4% |
| Q2 2017 | $10,675,000 | +58.9% | 1,156,606 | +85.0% | 0.16% | +63.9% |
| Q1 2017 | $6,716,000 | +271.0% | 625,268 | +190.8% | 0.10% | +203.1% |
| Q4 2016 | $1,810,000 | – | 215,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|